Clinical Trials: Solid Tumors

California

Duarte; City of Hope
Pilot Study of Dose Adjustment of Vinorelbine in Patients with Varying Degree of Liver Dysfunction

Duarte; City of Hope
A Phase I Trial of PS-341 in Combination with Topotecan in Advanced Solid Tumor Malignancies

Duarte; City of Hope
PHI-54 NCI #7540: Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Malignant Solid Tumors

Duarte; City of Hope
Passport for Care: Implementation in Multiple Institutions

Duarte; City of Hope
PHI-61 NCI#7967: A Phase I Study of ABT-888 in Combination with Carboplatin and Paclitaxel in Advanced Solid Malignancies

Duarte; City of Hope
Evaluation of BCL-XL Specific Immunity

Duarte; City of Hope
Innovative Underserved Community-Based Cancer Risk Screening

Duarte; City of Hope
COG ALTE03N1: Key Adverse Events After Childhood Cancer

Duarte; City of Hope
PHI-52 NCI#7225: A Phase I and Pharmacokinetic Study of Oral 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine)in the Treatment of Advanced Solid Tumors

Duarte; City of Hope
PHI-55 NCI#7427: A Phase I Study of Halichondrin B Analog (E7389) in Combination with Cisplatin in Advanced Solid Tumors

Duarte; City of Hope
SWOG S0528: Phase I Study Evaluating the Combination of Lapatinib (GW572016 NSC-727989, IND-75,093) and Everolimus(RAD001; NSC-733504; IND 75, 093) in Patients with Advanced Solid Tumors

Duarte; City of Hope
A Phase I Study of Bortezomib and Temozolomide in Patients with Refractory Solid Tumors

Duarte; City of Hope
PHI-53 NCI#7251: A Phase I Trial of PXD101 in Combination with 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies

Duarte; City of Hope
A Phase I Safety and Pharmacokinetic Study of IT-101 in the Treatment of Advanced Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Study of BIIB015 in Patients with Cripto-Positive Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Study of IPI-493 in Patients with Advanced Malignancies

Santa Monica; Premiere Oncology
A Phase I Study of TRC102 in Combination with Alimta in Patients with Advanced Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Study of Asonep in Subjects with Refractory Advanced Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Study of SSR244738 (TED5799) in Patients with Refractory Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Study of CVX-045 in Patients with Advanced Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Study of XL518 in Subjects with Advanced Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Study of Indibulin in Advanced Solid Tumors

Santa Monica; Premiere Oncology
A Phase 1 Study of S-1 Administered in Combination with Taxotere

Santa Monica; Premiere Oncology
A Phase 1 Study of Bavituximab in Patients with Solid Tumors

Santa Monica; Premiere Oncology
A Phase I study or SGX523 in Patients with Advanced Cancer

Santa Monica; Premiere Oncology
A Phase I Study of BIIB021 Administered Once or Twice Daily to Subjects with Advanced Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Study of ARQ 197 in Combination with Tarceva in Patients with Advanced Solid Tumors

Santa Monica; Premiere Oncology
A Study Evaluating the Pharmacokinetics of S-1 in patients with impaired renal function

Santa Monica; Premiere Oncology
A Phase I Study of MP470 in Combination with Standard of Care Chemotherapy Regimens

Santa Monica; Premiere Oncology
A Phase I Study of the HSP90 Inhibitor STA-9090 in Patients with Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Trial of CVX-060, an Anti-Angiogenic COVX-BODY in Patients with Advanced Solid Tumors

Santa Monica; Premiere Oncology
A Phase I Study of VEGF Trap Administered with Gemzar and Tarceva

Santa Monica; Premiere Oncology
A Phase I Dose Finding Study of TRC105 in Patients with Advanced or Metastatic Solid Cancer

Santa Monica; Premiere Oncology
A Phase 2 Study of ARQ 197 in Patients with Microphthalmia Transciption Factor Associated Tumors

Connecticut

Various Cities; Research Center
Advanced Solid Tumors Study CLBH589B2111

Maryland

Baltimore; National Institute on Aging
A Phase 1b Trial of the Combination of Bryostatin-1 and Low Dose Interleukin-2: Evaluation of the Functional and Molecular Status of Human Monocytes as Antigen Presenting cells

Various Cities; Research Center
Advanced Solid Tumors Study CLBH589B2111

Massachusetts

Boston; Dana Farber Cancer Institute
A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors

Boston; Dana Farber Cancer Institute
An open-label dose escalation study of patients with solid tumors treated with STA-9090

Various Cities; Research Center
Advanced Solid Tumors Study CLBH589B2111

Michigan

Detroit; Wayne State University Karmanos Cancer Institute
A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors

Detroit; Wayne State University Karmanos Cancer Institute
An open-label dose escalation study of patients with solid tumors treated with STA-9090

New Hampshire

Various Cities; Research Center
Advanced Solid Tumors Study CLBH589B2111

Ohio

Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children with Refractory Solid Tumors or Refractory Leukemias

Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
ADVL0612: A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors

Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Phase I Study of Depsipeptide in Pediatric Patients with Refractory Solid Tumors

Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Phase Study of Temozolomide, Oral Irinotecan, and Vincristine for Children with Refractory Solid Tumors

Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Phase Study of Temozolomide, Oral Irinotecan, and Vincristine for Children with Refractory Solid Tumors

Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Phase II Study of Sulindac and Tamoxifen in Patients with Desmoid Tumors that are Recurrent or Not Amenable to Standard Therapy

Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Phase 1 Study of SAHA in Pediatric Patients with Recurrent or Refractory Solid Tumors (Including Lymphomas) and Leukemia Followed by a Phase I Study of SAHA in Combination with 13 Cis-Retinoic Acid for Patients with Selected Recurrent/Refractory Solid Tumors

Texas

San Antonio; The Institute For Drug Development
A phase 1 study of LP-261-01 in patients with advanced solid malignancies.

International

Baden Wuerttemberg, Germany; Clinic SanaFontis
Study to evaluate the clinical benefit response of a new drug AMT vs Placebo in advanced cancer patients with esophagus, colon, pancreas, lung, gastric, liver, gall bladder, prostate and female reproductive system cancers